NSEGranting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals22 Oct 2026 · 22 Oct 2026, 11:13 am
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Jaykay Enterprises Limited · JAYKAY
✦ AI Summary▲ PositiveRegulatory
Jaykay Enterprises Limited has informed the Exchange about receipt of Licence to Manufacture for Sale or for Distribution of Class C or Class D Medical Devices by JK Digital & Advance Systems Private Limited, a wholly owned subsidiary of the Company.
Analysis Scores
Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk5/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jaykay Enterprises Limited has informed the Exchange about receipt of Licence to Manufacture for Sale or for Distribution of Class C or Class D Medical Devices by JK Digital & Advance Systems Private Limited, WOS of the Company
Attachments (1)
📄pdf
Download →
JAYKAY_22102026111322_SE_Intimation_merged_signed.pdf
View document text
October 22, 2026
BSE Limited National Stock Exchange of India Ltd.
Listing Department Exchange Plaza, 5th Floor,
Phiroze Jeejeebhoy Towers Plot No. C-1, G Block,
Dalal Street, Bandra-Kurla Complex, Bandra (E),
Mumbai - 400001 Mumbai - 400051
Scrip Code: 500306 / 890240 NSE Symbol: JAYKAY / JAYKAYPP
Sub: Intimation regarding receipt of Licence to Manufacture for Sale or for Distribution of Class C or
Class D Medical Devices by JK Digital & Advance Systems Private Limited, WOS of Jaykay
Enterprises Limited
Re: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015
Dear Sir/Madam,
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we would like to inform you that:
JK Digital & Advance Systems Private Limited (“JK Digital”), a wholly owned subsidiary of Jaykay Enterprises
Limited (the “Company”), has received a Licence to Manufacture for Sale or for Distribution of Class C or
Class D Medical Devices, bearing Licence No. MFG/MD/2026/000784 dated 21 October 2026, issued by the
Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of
Health & Family Welfare, Government of India, under the Medical Devices Rules, 2017.
The licence covers the following eight categories of advanced medical implants:
1. Lattice Acetabular Cups: for complex hip revision surgeries and reconstruction of severe acetabular bone
defects.
2. Lattice Cone Acetabular Cups: for complex hip revision surgeries and reconstruction of severe acetabular
bone defects.
3. Lattice Buttress Implants: to provide structural support during revision total hip arthroplasty.
4. Lattice Shim Implants: for structural gap-filling and angular adjustment in hip reconstruction procedures.
5. Lattice Cage Constructs: for reconstruction of severe acetabular bone defects in complex primary or revision
hip replacement procedures.
6. Lattice TLIF Spinal Implants: implants used in transforaminal lumbar interbody fusion procedures.
7. Lattice PLIF Spinal Implants: implants used in posterior lumbar interbody fusion procedures.
8. Lattice Shells and Wedges: for augmentation, reconstruction and reinforcement of acetabular bone during
complex hip replacement procedures.
The licensed products are specified as being manufactured using titanium alloy powder (Ti6Al4V) and are
covered under the brand names Neobone and Nubone.
The receipt of this licence marks an important regulatory milestone for JK Digital and establishes the regulatory
authorisation to manufacture the specified specialised orthopaedic and spinal implant products, subject to the
terms and conditions of the licence and applicable regulatory requirements.
Regd. Office: Kamla Tower, Kanpur- 208001 (INDIA)
Phones: +91 512 2371478 – 81
E-mail: cs@jaykayenterprises.com, Web: www.jaykayenterprises.com CIN: L55101UP1961PLC001187
This development further strengthens the Company’s presence in the specialised medical devices segment and
provides a regulatory foundation for pursuing opportunities in advanced orthopaedic and spinal implant solutions.
A copy of the manufacturing licence along with the covering communication issued by CDSCO is enclosed
herewith.
The relevant details pertaining to the above as required under Regulation 30 of the SEBI Listing Regulations read
with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“SEBI
Circular”) are enclosed herewith as Annexure - A.
This disclosure will also be hosted on Company’s website viz. www.jaykayenterprises.com.
Kindly take the same on record.
Thanking you,
Yours faithfully
For Jaykay Enterprises Limited
Shikha Rastogi
Company Secretary & Compliance Officer
Encl.: As above
Regd. Office: Kamla Tower, Kanpur- 208001 (INDIA)
Phones: +91 512 2371478 – 81
E-mail: cs@jaykayenterprises.com, Web: www.jaykayenterprises.com CIN: L55101UP1961PLC001187
Annexure-A
Disclosure as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular is as under:
S. No. Particulars Description
1. Name of the regulatory or Central Drugs Standard Control Organisation (CDSCO), Directorate
licensing authority General of Health Services, Ministry of Health & Family Welfare,
Government of India
2. Brief details of the Licence to Manufacture for Sale or for Distribution of Class C or Class
approval/license D Medical Devices, bearing Licence No. MFG/MD/2026/000784 dated
obtained 21 October 2026, issued under the Medical Devices Rules, 2017.
The licence covers the following eight categories of advanced medical
implants:
1. Lattice Acetabular Cups: for complex hip revision surgeries and
reconstruction of severe acetabular bone defects.
2. Lattice Cone Acetabular Cups: for complex hip revision surgeries
and reconstruction of severe acetabular bone defects.
3. Lattice Buttress Implants: to provide structural support during
revision total hip arthroplasty.
4. Lattice Shim Implants: for structural gap-filling and angular
adjustment in hip reconstruction procedures.
5. Lattice Cage Constructs: for reconstruction of severe acetabular
bone defects in complex primary or revision hip replacement
procedures.
6. Lattice TLIF Spinal Implants: implants used in transforaminal
lumbar interbody fusion procedures.
7. Lattice PLIF Spinal Implants: implants used in posterior lumbar
interbody fusion procedures.
8. Lattice Shells and Wedges: for augmentation, reconstruction and
reinforcement of acetabular bone during complex hip replacement
procedures.
3. Impact/relevance of such The receipt of this licence marks an important regulatory milestone for
approval/ license to the JK Digital & Advance Systems Private Limited and establishes the
listed entity regulatory authorisation to manufacture the specified specialised
orthopaedic and spinal implant products, subject to the terms and
conditions of the licence and applicable regulatory requirements.
This development strengthens the presence of Jaykay Enterprises
Limited in the specialised medical devices segment and provides a
regulatory foundation for pursuing opportunities in advanced
orthopaedic and spinal implant solutions.
4. Period for which such Lifetime
approval/license is/was
valid
Regd. Office: Kamla Tower, Kanpur- 208001 (INDIA)
Phones: +91 512 2371478 – 81
E-mail: cs@jaykayenterprises.com, Web: www.jaykayenterprises.com CIN: L55101UP1961PLC001187
Central Drugs Standard Control Organisation
Directorate General of Health Services
Ministry of Health & Family Welfare
(Medical Device & Diagnostic Division)
FDA Bhawan, Kotla Road
New Delhi-110002
Phone No-011-23236965
Fax: 23236973
File No. : Bangalore(SZ)/MD/2026/000060
Dated : 21-OCT-2026
M/s JK DIGITAL & ADVANCE SYSTEMS
PRIVATE LIMITED,
4th Floor, JK Building, Masjid Road, A-2
Local Shopping Centre
New Delhi, South Delhi, Delhi (India) -
110048
Telephone No.: 09971004394 FAX:
01140823320 Email:
accounts.jkel@jkorg.co.in
Sub:- Licence to manufacture for Sale or for Distribution of Class C or Class D medical devices in
Form MD-9 under Medical Device Rules, 2017- regarding.
Sir,
Manufacturing licence No. MFG/MD/2026/000784 in Form MD-9 is hereby forwarded to you.
This licence is subject to following conditions:
1. Licence shall be produced when requested by the Medical Device Officer or any other senior
officer under the control of Central Licensing Authority.
2. The licence holder shall inform the Central Licensing Authority of the occurrence of any
suspected unexpected serious adverse event and action taken thereon including any recall
within fifteen days of such event coming to the notice of licence holder
3. The licence holder shall obtain prior approval from the Central Licensing Authority, before
any major change as specified in the Sixth Schedule is carried out and the Central Licensing
Authority shall indicate its approval or rejection within forty five days and in case where no
communication is received within the sti
[Showing first 8,000 characters — download PDF for full document]